Details of the Drug

General Information of Drug (ID: DMO41UZ)

Drug Name
Anti-miR-191 modified oligonucleotide
Indication
Disease Entry ICD 11 Status REF
Hepatocellular carcinoma 2C12.02 Investigative [1]
Drug Type
Antisense drug
Cross-matching ID
TTD ID
D0IC2O

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
microRNA hsa-miR-191 (MIR191) TT3ULBR NOUNIPROTAC Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res. 2010 Oct 15;70(20):8077-87.